TMCnet News
G1 Therapeutics to Present at UBS Global Healthcare ConferenceRESEARCH TRIANGLE PARK, N.C., May 13, 2019 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that Chief Executive Officer Mark Velleca, M.D., Ph.D. will present a company overview at the UBS Global Healthcare Conference. The presentation will take place on Tuesday, May 21 at 4:00 p.m. ET at the Grand Hyatt New York in New York, NY. To access the live webcast presentation, please visit the Events & Presentations page within the Investors section of the G1 website. Replays of the webcasts will be archived on the same page for 90 days following the event. Abot G1 Therapeutics G1 is based in Research Triangle Park, NC. For additional information, please visit www.g1therapeutics.com and follow us on Twitter @G1Therapeutics. Contact: |